🇺🇸 FDA
Pipeline program

BMMNCs

CSCC/BMRP/2013//01

Phase 2 mab active

Quick answer

BMMNCs for Retinitis Pigmentosa is a Phase 2 program (mab) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Retinitis Pigmentosa
Phase
Phase 2
Modality
mab
Status
active

Clinical trials